[1]
“Outcome of Sorafenib Therapy in Advanced Hepatocellular Carcinoma”, J. Armed Forces Med. Coll., vol. 15, no. 1, pp. 16–18, Aug. 2020, doi: 10.3329/jafmc.v15i1.48633.